As described by Feig et al., combination treatment with depletion of FAP+ CAFs and administration of α-CTLA-4 or α-PD-L1 diminished the tumor growth by 15% after 6 days of treatment in KPC mice [81]. This evidence concerns the gene CTLA4 and neoplasm.